USFDA inspection: Alkem Labs concludes inspection at Taloja Center
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-03-15 09:54 GMT | Update On 2025-03-15 10:09 GMT
Advertisement
Mumbai: Alkem Labs has announced the completion of the inspection at the Company's Bioequivalence Center located at Taloja, Maharashtra.
The facility was inspected from 10th March, 2025 to 13th March, 2025.
"This is to inform you that US FDA had conducted a Bioresearch Monitoring (BIMO) inspection at the Company’s Bioequivalence Center located at Taloja, Maharashtra from 10th March, 2025 to 13th March, 2025," Alkem stated in a release.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.